Study day to highlight advances in oculoplastics

The day will offer delegates the opportunity to develop their knowledge, understanding and practical skills on a range of topics including  revolutionising the role of the oculoplastic nurse practitioner, lacrimal assessment, botulinum toxin research and counselling the oculoplastic patient.

This is the fourth oculoplastic and allied health professional study day and it features an array of expert speakers who will be discussing issues, treatments and outcomes surrounding oculoplastic surgery and advances in nursing and new innovations within the sector. Delegates will also have the opportunity to put their questions to clinical staff who are leading some of the sessions, including Moorfields’ consultant ophthalmic surgeon Mr David Verity and chief ocularist, David Carpenter. The day will also involve a new feature for this year in the form of a poster exhibition.

Nicola Dunlop, Moorfields’ advance nurse practitioner, who is the lead organiser for the event, said: This is the fourth instalment of the oculoplastic study day which promises to be a very informative occasion. We usually have both national and international delegates attending and this year we are introducing a poster exhibition.” 

For further information contact nicola.dunlop@moorfileds.nhs.uk.

The course cost is £75 and the venue is the Thistle City Barbican Hotel, Central Street, Clerkenwell, London EC1V 8DS.

Notes to editors

Press contact: Zainab Oyegoke – 020 7566 2628

• Moorfields is one of the world’s leading eye hospitals, providing expertise in clinical care, research and education. We have provided excellence in eye care for more than 200 years and we continue to be at the forefront of new breakthroughs and developments.  We are an integral part of one of the UK’s first academic health science centres, UCL Partners, and also one of the new academic health science networks. We were one of the first NHS organisations to achieve foundation trust status in 2004. 

• We treat the entire range of eye diseases, from common complaints to rare conditions which require treatments not available anywhere else in the UK. We dealt with more than 470,000 patient attendances in 2013/14 across our locations in and around London, enabling us to provide expert care closer to patients’ homes. • Our specialist A&E dealt with almost 90,000 patient visits in the year 2013/14.

• With our academic partners at the UCL Institute of Ophthalmology,Moorfields is recognised as a leading centre of excellence in eye and vision research. Together, we form one of the largest ophthalmic research sites in the world, with the largest patient population in Europe  or the USA. We publish more scientific papers than any other eye  and vision research site, and have an extensive joint research portfolio.          

For further information, please visit  www.moorfields.nhs.uk.

 

Was this information useful? Please rate the page.